Vascular Lesion

0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Lumenis
LumenisAustralia - Chatswood
3 programs
IPL with smart diagnostic handpieceN/A1 trial
IPL with smart diagnostic handpieceN/A1 trial
cameraN/A1 trial
Active Trials
NCT05630690Unknown20Est. Apr 2024
NCT05755139Completed60Est. Aug 2023
NCT05674149Unknown210Est. Mar 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
LumenisIPL with smart diagnostic handpiece
Lumeniscamera
LumenisIPL with smart diagnostic handpiece

Clinical Trials (3)

Total enrollment: 290 patients across 3 trials

NCT05630690LumenisIPL with smart diagnostic handpiece

Evaluation of Safety and Efficacy of IPL Presets for Cutaneous Lesions

Start: Oct 2023Est. completion: Apr 202420 patients
N/AUnknown

Image Data Collection Using a Multi-spectral Camera for Computer Vision Algorithms Research and Development

Start: Jun 2023Est. completion: Mar 2024210 patients
N/AUnknown
NCT05755139LumenisIPL with smart diagnostic handpiece

Safety and Efficacy Evaluation of SMART Camera Treatment Presets for Cutaneous Lesions Using IPL

Start: Dec 2022Est. completion: Aug 202360 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space